Post-natalizumab clinical and radiological findings in a cohort of multiple sclerosis patients: 12-month follow-up

Lethal multiple sclerosis relapse after natalizumab withdrawal

(2012) V. Rigau et al.   NEUROLOGY

Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy

(2012) Gary Bloomgren et al.   NEW ENGLAND JOURNAL OF MEDICINE

Pulse monthly steroids during an elective interruption of natalizumab: a post-marketing study

(2011) G. Borriello et al.   EUROPEAN JOURNAL OF NEUROLOGY

Disease activity return during natalizumab treatment interruption in patients with multiple sclerosis

(2011) P. W. O'Connor et al.   NEUROLOGY

Natalizumab drug holiday in multiple sclerosis: Poorly Tolerated

(2010) Joep Killestein et al.   ANNALS OF NEUROLOGY

Considerations on discontinuing natalizumab for the treatment of multiple sclerosis

(2010) Joseph R. Berger et al.   ANNALS OF NEUROLOGY

Anti-JC virus antibodies: Implications for PML Risk Stratification

(2010) Leonid Gorelik et al.   ANNALS OF NEUROLOGY

Immune Reconstitution Inflammatory Syndrome in Patients With Multiple Sclerosis Following Cessation of Natalizumab Therapy

(2010) Augusto Miravalle et al.   ARCHIVES OF NEUROLOGY

Course of relapsing–remitting multiple sclerosis before, during and after natalizumab

(2010) Michael D Kaufman et al.   Multiple Sclerosis Journal

Observations during an elective interruption of natalizumab treatment: a post-marketing study

(2010) Giovanna Borriello et al.   Multiple Sclerosis Journal

IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME AFTER WITHDRAWAL OF NATALIZUMAB?

(2010) T. Lenhard et al.   NEUROLOGY

Balancing risk and reward: The question of natalizumab

(2009) Stephen L. Hauser et al.   ANNALS OF NEUROLOGY